iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

NCT04808791 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Junction Adenocarcinoma
Advanced Gastric Carcinoma

Interventions

DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: TAS 102 (Trifluridine/Tipiracil)

Sponsor

AHS Cancer Control Alberta